A particular combination of bacteria in the gut could worsen symptoms of multiple sclerosis (MS), research suggests. Researchers at the RIKEN Center for Integrative Medical Sciences...
A round up of the latest developments in Multiple Sclerosis (MS) research.
“It’s not the cards you’re dealt that matters, it’s how you play them that counts.” For Jessie Ace, this is a mantra that inspires her every...
The Scottish Medicines Consortium (SMC) has accepted fampridine (Fampyra) for MS patients. The medicine, produced by Biogen Inc, is available to people scoring 4-7 on the Expanded...
A new study has evaluated the value of cognitive rehabilitation in addressing the thinking problems experienced by some people with MS.
A popular fitness challenge which supports UK multiple sclerosis causes is back for 2020.
The treatment landscape for Scottish MS patients has been bolstered by a landmark decision.
People with MS in England and Wales are being urged to play their part in helping to ensure the MS drug siponimod becomes available on the...
A UK study which aims to collect game-changing data about life with MS has received £1m in investment from the MS Society.